Bone marrow-derived microglia in pilocytic astrocytoma

Wafa AlShakweer1, Yazeed Alwelaie, Aaron M Mankung

  • 1Division of Neuropathology, Department of Pathology and Clinical Laboratory Medicine, Faculty of Medicine, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.

Insights

Tumour-associated macrophages (TAMs) in pilocytic astrocytomas (PAs) exhibit M2 markers. Macrophage recruitment into PAs suggests a model for studying glioma infiltration.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cell Biology

Background:

  • Tumour-associated macrophages (TAMs) are increasingly recognized for their role in supporting tumor growth.
  • Malignant gliomas feature tumour-associated microglia/macrophages (TAMs) with a predominant CD163 immunophenotype.

Purpose of the Study:

  • To investigate the presence and phenotype of M2 macrophages in benign pilocytic astrocytomas (PAs).
  • To determine if TAMs in PAs share the CD163 immunophenotype with those in malignant gliomas.
  • To explore the origin of macrophages in PAs, differentiating between resident microglia and vasculature-derived cells.

Main Methods:

  • Immunohistochemical analysis of pilocytic astrocytoma (PA) tissue samples.
  • Morphological assessment to identify macrophage infiltration and origin.

Main Results:

  • Strong morphological evidence suggests macrophage recruitment into pilocytic astrocytomas (PAs) from the vasculature.
  • Pilocytic astrocytomas (PAs) show the presence of M2 macrophages.
  • Microglia/macrophage infiltration alone does not correlate with malignant glioma behavior.

Conclusions:

  • Pilocytic astrocytomas (PAs) serve as a valuable model for studying macrophage recruitment into gliomas.
  • Macrophage infiltration into the central nervous system (CNS) via vasculature is supported by findings in PAs.
  • The study confirms that microglia/macrophage infiltration is not inherently linked to malignant glioma progression.

Related Concept Videos